Hydrostatic pressure under hypoxia facilitates fabrication of tissue-engineered vascular grafts derived from human vascular smooth muscle cells in vitro

被引:5
作者
Kojima, Tomoyuki [1 ,2 ]
Nakamura, Takashi [1 ]
Saito, Junichi [1 ]
Hidaka, Yuko [1 ]
Akimoto, Taisuke [3 ]
Inoue, Hana [1 ]
Chick, Christian Nanga [4 ]
Usuki, Toyonobu [4 ]
Kaneko, Makoto [5 ]
Miyagi, Etsuko [2 ]
Ishikawa, Yoshihiro [6 ]
Yokoyama, Utako [1 ,7 ]
机构
[1] Tokyo Med Univ, Dept Physiol, Tokyo 1600023, Japan
[2] Yokohama City Univ, Grad Sch Med, Dept Obstet & Gynecol, Yokohama, Kanagawa 2360004, Japan
[3] Yokohama City Univ, Grad Sch Med, Dept Neurosurg, Yokohama, Kanagawa 2360004, Japan
[4] Sophia Univ, Fac Sci & Technol, Dept Mat & Life Sci, Tokyo 1028554, Japan
[5] Meijo Univ, Grad Sch Sci & Technol, Nagoya, Aichi 4688502, Japan
[6] Yokohama City Univ, Grad Sch Med, Cardiovasc Res Inst, Yokohama, Kanagawa 2360004, Japan
[7] Tokyo Med Univ, Dept Physiol, 6-1-1 Shinjuku, Shinjuku Ku, Tokyo 1608402, Japan
关键词
Hydrostatic pressure; Hypoxia; Cell-matrix junctions; Extracellular matrix; Tissue engineering; CCAAT/ENHANCER-BINDING PROTEIN; LYSYL OXIDASE; TRANSCRIPTIONAL ACTIVITY; MECHANICAL-PROPERTIES; EXTRACELLULAR-MATRIX; BLOOD-VESSELS; FIBRONECTIN; EXPRESSION; ARTERIAL; PATHWAYS;
D O I
10.1016/j.actbio.2023.09.041
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Biologically compatible vascular grafts are urgently required. The scaffoldless multi-layered vascular wall is considered to offer theoretical advantages, such as facilitating cells to form cell-cell and cell-matrix junctions and natural extracellular matrix networks. Simple methods are desired for fabricating physiological scaffoldless tissue-engineered vascular grafts. Here, we showed that periodic hydrostatic pressurization under hypoxia (HP/HYP) facilitated the fabrication of multi-layered tunica media entirely from human vascular smooth muscle cells. Compared with normoxic atmospheric pressure, HP/HYP increased expression of N-myc downstream-regulated 1 (NDRG1) and the collagen-cross-linking enzyme lysyl oxidase in human umbilical artery smooth muscle cells. HP/HYP increased N-cadherin-mediated cell-cell adhesion via NDRG1, cell-matrix interaction (i.e., clustering of integrin alpha 5 beta 1 and fibronectin), and collagen fibrils. We then fabricated vascular grafts using HP/HYP during repeated cell seeding and obtained 10-layered smooth muscle grafts with tensile rupture strength of 0.218-0.396 MPa within 5 weeks. Implanted grafts into the rat aorta were endothelialized after 1 week and patent after 5 months, at which time most implanted cells had been replaced by recipient-derived cells. These results suggest that HP/HYP enables fabrication of scaffoldless human vascular mimetics that have a spatial arrangement of cells and matrices, providing potential clinical applications for cardiovascular diseases. Statement of significance Tissue-engineered vascular grafts (TEVGs) are theoretically more biocompatible than prosthetic materials in terms of mechanical properties and recipient cell-mediated tissue reconstruction. Although some promising results have been shown, TEVG fabrication processes are complex, and the ideal method is still desired. We focused on the environment in which the vessels develop in utero and found that mechanical loading combined with hypoxia facilitated formation of cell-cell and cell-matrix junctions and natural extracellular matrix networks in vitro, which resulted in the fabrication of multi-layered tunica media entirely from human umbilical artery smooth muscle cells. These scaffoldless TEVGs, produced using a simple process, were implantable and have potential clinical applications for cardiovascular diseases. (c) 2023 The Authors. Published by Elsevier Ltd on behalf of Acta Materialia Inc. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
引用
收藏
页码:209 / 222
页数:14
相关论文
共 50 条
  • [31] Application of Human Induced Pluripotent Stem Cells in Generating Tissue-Engineered Blood Vessels as Vascular Grafts
    Cong, Xiaoqiang
    Zhang, Shang-Min
    Batty, Luke
    Luo, Jiesi
    STEM CELLS AND DEVELOPMENT, 2019, 28 (24) : 1581 - 1594
  • [32] Technology Insight: the evolution of tissue-engineered vascular grafts - from research to clinical practice
    L'Heureux, Nicolas
    Dusserre, Nathalie
    Marini, Alicia
    Garrido, Sergio
    de la Fuente, Luis
    McAllister, Todd
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2007, 4 (07): : 389 - 395
  • [33] Biomimetic control of vascular smooth muscle cell morphology and phenotype for functional tissue-engineered small-diameter blood vessels
    Chan-Park, Mary B.
    Shen, Jin Ye
    Cao, Ye
    Xiong, Yun
    Liu, Yunxiao
    Rayatpisheh, Shahrzad
    Kang, Gavin Chun-Wei
    Greisler, Howard P.
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2009, 88A (04) : 1104 - 1121
  • [34] Engineering vascular tissue with functional smooth muscle cells derived from human iPS cells and nanofibrous scaffolds
    Wang, Yongyu
    Hu, Jiang
    Jiao, Jiao
    Liu, Zhongning
    Zhou, Zhou
    Zhao, Chao
    Chang, Lung-Ji
    Chen, Y. Eugene
    Ma, Peter X.
    Yang, Bo
    BIOMATERIALS, 2014, 35 (32) : 8960 - 8969
  • [35] Determining the fate of seeded cells in venous tissue-engineered vascular grafts using serial MRI
    Harrington, Jamie K.
    Chahboune, Halima
    Criscione, Jason M.
    Li, Alice Y.
    Hibino, Narutoshi
    Yi, Tai
    Villalona, Gustavo A.
    Kobsa, Serge
    Meijas, Dane
    Duncan, Daniel R.
    Devine, Lesley
    Papademetri, Xenophon
    Shin'oka, Toshiharu
    Fahmy, Tarek M.
    Breuer, Christopher K.
    FASEB JOURNAL, 2011, 25 (12) : 4150 - 4161
  • [36] In Vivo Functional Evaluation of Tissue-Engineered Vascular Grafts Fabricated Using Human Adipose-Derived Stem Cells from High Cardiovascular Risk Populations
    Krawiec, Jeffrey T.
    Weinbaum, Justin S.
    Liao, Han-Tsung
    Ramaswamy, Aneesh K.
    Pezzone, Dominic J.
    Josowitz, Alexander D.
    D'Amore, Antonio
    Rubin, J. Peter
    Wagner, William R.
    Vorp, David A.
    TISSUE ENGINEERING PART A, 2016, 22 (9-10) : 765 - 775
  • [37] Engineered Microenvironment for Manufacturing Human Pluripotent Stem Cell-Derived Vascular Smooth Muscle Cells
    Lin, Haishuang
    Qiu, Xuefeng
    Du, Qian
    Li, Qiang
    Wang, Ou
    Akert, Leonard
    Wang, Zhanqi
    Anderson, Dirk
    Liu, Kan
    Gu, Linxia
    Zhang, Chi
    Lei, Yuguo
    STEM CELL REPORTS, 2019, 12 (01): : 84 - 97
  • [38] Tissue-engineered vascular grafts for use in the treatment of congenital heart disease: from the bench to the clinic and back again
    Patterson, Joseph T.
    Gilliland, Thomas
    Maxfield, Mark W.
    Church, Spencer
    Naito, Yuji
    Shinoka, Toshiharu
    Breuer, Christopher K.
    REGENERATIVE MEDICINE, 2012, 7 (03) : 409 - 419
  • [39] Human adipose-derived stromal cells for the production of completely autologous self-assembled tissue-engineered vascular substitutes
    Vallieres, Karine
    Laterreur, Veronique
    Tondreau, Maxime Y.
    Ruel, Jean
    Germain, Lucie
    Fradette, Julie
    Auger, Francois A.
    ACTA BIOMATERIALIA, 2015, 24 : 209 - 219
  • [40] Comparison of the Biological Equivalence of Two Methods for Isolating Bone Marrow Mononuclear Cells for Fabricating Tissue-Engineered Vascular Grafts
    Kurobe, Hirotsugu
    Tara, Shuhei
    Maxfield, Mark W.
    Rocco, Kevin A.
    Bagi, Paul S.
    Yi, Tai
    Udelsman, Brooks V.
    Dean, Ethan W.
    Khosravi, Ramak
    Powell, Heather M.
    Shinoka, Toshiharu
    Breuer, Christopher K.
    TISSUE ENGINEERING PART C-METHODS, 2015, 21 (06) : 597 - 604